Gender Male
LinkedIn View on LinkedIn
John P. Sharp is the chief financial officer of PhaseBio Pharmaceuticals, a clinical-stage biopharmaceutical company committed to developing new and improved bio therapeutics. Previously, he held the position of chief financial officer at various pharmaceutical companies, including HUYA Bioscience International and Ligand Pharmaceuticals.
Prior to
joining Ligand, Sharp served as the vice president of finance and principal accounting officer for Sequenom. While at Sequenom, he played an important management role, responsible for worldwide accounting, SEC reporting, financial and administrative management, and investor relations. From 2000 to 2004, he served as the director of accounting at Diversa Corporation, a publicly traded biotech company, where he was responsible for managing the overall accounting function, including financial reporting, internal controls, and corporate governance, during a period of significant company growth.
From 1994 to 2000, Sharp was at the public accounting firm PricewaterhouseCoopers, most recently as a senior audit manager. He received a Bachelor of Science degree from San Diego State University, and is a certified public accountant and a member of the Association of Bioscience Financial Officers.
